Introduction
Human papillomaviruses (HPVs) are small DNA tumour viruses, which can infect mucosal and cutaneous epithelia, giving rise to benign hyperproliferative lesions. These lesions are under host immune surveillance and can regress spontaneously. Of the greater than 100 papillomaviruses now typed, roughly 30 types preferentially infect the mucosa of the anogenital tract. These HPVs can be grouped into high-and low-risk types. The high-risk types are those inducing lesions that can progress to squamous cell carcinoma. The rate of progression may be low, but nevertheless infection with high-risk HPVs accounts for nearly all-human cervical cancers (for a review, see zur Hausen, 1996) . The HPV types most commonly linked with genital cancer are 16 and 18, and less frequently types 31, 33, 35 and 39. As well as genital cancer these high-risk viruses have been linked to oropharyngeal carcinoma (Gillison et al., 2000) .
High-risk HPV encode at least three different growth stimulating and transforming proteins: E5, E6 and E7. These proteins have an expanding number of cellular targets and functions (for a review, see zur Hausen, 2000) . E6 targets several tumour suppressor and antiapoptotic proteins, perhaps the most important of which is p53 (Mantovani and Banks, 2001) . These interactions cause the rapid degradation of the target proteins with consequent cell immortalization. The E5 protein from HPV interacts with the 16K subunit c protein in mammalian cells and yeast (Conrad et al., 1993; Ashby et al., 2001 ) and, through this interaction, downregulates gap junction intercellular communication (Oelze et al., 1995) and alters the acidification of endosomes (Straight et al., 1995) leading to continuous signalling from growth factors receptors. The E7 oncoprotein has many roles (for a review, see Munger et al., 2001) . One main function of E7 is to bind the pocket proteins causing the dissociation of the transcription factor E2F. Additionally, E7 causes the destabilization of the p105Rb protein (Boyer et al., 1996; Jones et al., 1997b) and interferes with the association between histone deacetylase and p105Rb (Brehm et al., 1998) . Among the other cellular factors with which E7 is thought to interact are the cyclindependent kinase inhibitors (cdkis) p21
Waf1 and p27
Kip1
. These proteins are potent inhibitors of cyclin E and A complexes, and may be positive regulators of the cyclin D complexes (Sherr and Roberts, 1999 for a review). E7 directly binds to p21
Waf1 and inhibits both its effect on the cyclin/cdk complexes and ability to inhibit DNA replication by binding PCNA (Jones et al., 1997a; Funk et al., 1997) . The related cdki, p27 Kip1 , is also bound by E7, resulting in abrogation of the inhibitory activity on cyclin/cdk complexes (Zerfass- Thome et al., 1996) . The combination of the HPV16 E6 and E7 oncoproteins has been shown to be sufficient to immortalize primary human keratinocytes (HawleyNelson et al., 1989) .
Progression of papillomavirus (PV)-induced lesions to carcinoma requires cofactors. In the case of cervical carcinoma, some of the cofactors have been identified, for example, immunosuppression, smoking, oestrogen and progesterone (Dell and Gaston, 2001 and references therein) . A detailed study of the nature of the cocarcinogens and their interaction with PV has been conducted in cattle. Infection of the upper gastrointestinal (GI) tract of cattle with BPV-4 causes benign papillomas. These papillomas can progress to carcinoma in cattle feeding on bracken fern. During progression, the Ha-ras oncogene becomes activated and the p53 gene undergoes mutations, highlighting the interaction between the mutagens present in the fern and the virus (Campo et al., 1994) . Quercetin is a potent mutagen widespread in nature but at its highest levels in bracken fern (Bjieldanes and Chang, 1977; Nakayasu et al., 1986) . It causes oxidative DNA damage (Yamashita and Kawanishi, 2000) , single-strand DNA breaks (Fazal et al., 1990) , DNA rearrangements (Suzuki et al., 1991) and chromosomal aberrations (Ishidate et al., 1988) . Additionally, quercetin interferes with several kinases (Jackson and Campo, 1995; Davies et al., 2000) . In our in vitro experimental model of BPV-4-associated oesophageal cancer, we found that quercetin could cause full oncogenic transformation of primary bovine fibroblasts partially transformed by BPV-4 and activated Ha-ras (Pennie and Campo, 1992; Cairney and Campo, 1995) . This transformation was ascribed to the expression of BPV-4 E7 overcoming a quercetin-induced G1 arrest mediated by p53, leading to the accumulation of mutations, including, as in vivo, mutations of the p53 gene (Beniston et al., 2001) .
HPV16 has been associated with up to 50% of oesophageal precancers and cancers particularly in developing countries (Chang et al., 1990; Togawa et al., 1994; Cooper et al., 1995; Suzuk et al., 1996; de Villiers et al., 1999; Syrjanen, 2002) . The highly variable geographical incidence of oesophageal cancer and of HPV detection in the cancer suggest a multifactorial aetiology and the involvement of environmental dietary cofactors (Syrjanen, 2002) . Some human populations are exposed to bracken fern and this exposure has been linked epidemiologically to cancer of the upper GI tract in several parts of the developed and developing world (Hirayama, 1979; Galpin et al., 1990; Villalobos-Salazar et al., 1995; Alonso-Amelot et al., 1996; Marliere et al., 2000) .
Given the possibility that papillomavirus infection and bracken fern are associated with oesophageal cancer in humans, as they are in cattle, and that quercetin promotes oncogenic transformation of BPV-transformed cells, we decided to assay whether quercetin played a role in transformation of human keratinocytes by HPV.
Materials and methods

Plasmids
pCH110 carries the LacZ reporter gene driven by the SV40 early promoter (Pharmacia, Herefordshire, UK). pl34-11 was a kind gift from Dr G Sonenshein (Boston, USA) and has the human p27
Kip1 promoter upstream of the firefly luciferase gene. pLXSN, pLXSN16E6, pLXSN16E7 and pLXSN16E6E7 are retroviral vectors containing the HPV16 E6, E7 or E6 and E7 genes (kind gift from Dr D Galloway, Seattle, USA).
Tissue culture
The retroviral vector constructs (pLXSN) were transfected in the packaging cell line Phoenix Ampho, cultured using DMEM supplemented with 10% foetal calf serum at 371C, 5% CO 2 (Invitrogen Carlsbad, CA, USA). At 24 h after transfection, the supernatant was taken and cell debris was spun out. The virus containing supernatant was stored at À701C until further use. Primary human foreskin keratinocytes (HFKs) (Bio-Whittaker, Berks, UK) were routinely cultured in KGM-2 medium (Bio-Whittaker) at 371C, 5% CO 2 being split 1 in 4 when 80-90% confluent. HFKE6/E7 were generated from HFKs being infected with recombinant retrovirus. To infect primary HFK cells 24 h before infection, 2 Â 10 5 cells were seeded into 25 cm 2 flasks with 5 ml of media. Infection mix (1.5 ml) was overlaid on the cells for 6 h at 371C before being removed and replaced with 15 ml of media. G418 selection of cells was started 24 h after infection at 500 mg/ml for 14-21 days. Stable HFKE6/E7 cells were routinely cultured in KGM-2 medium (Bio-Whittaker) with the addition of 500 mg/ml G418 (Invitrogen,) at 371C, 5% CO 2 and split 1 in 4 when 80-90% confluent. HaCaT cells were grown in DMEM without CaCl 2 , supplemented with 1 mm sodium pyruvate and 2 mm glutamine and 10% foetal calf serum (FCS) at 371C, 5% CO 2 and split 1 in 6 when 80-90% confluent.
Cell proliferation was assayed by cell counts. HFKE6/E7 cells were seeded into 100 mm tissue culture plates (8 Â 10 5 / plate) and then left for 24 h before being treated with 0, 5, 10 or 20 mm quercetin. Cells were treated for 24, 48 or 72 h, with new medium being added with fresh quercetin or EtOH every 24 h. Cells were trypsinzed, resuspended in 6 ml of 5% FCS in PBS and counted in duplicate in a haemocytometer.
Cell cycle analysis
Cells (5 Â 10 5 ) were plated into 100 mm dishes and 24 h later treated with 5, 10, 20 or 50 mm quercetin in EtOH (SigmaAldrich) for 36 h. Control cells (0 mm) were treated with an equal volume of solvent (EtOH). Cells were trypsinized and centrifuged at 1000 r.p.m. at room temperature for 10 min. The supernatant was then removed before cells were resuspended in 0.5 ml of IFA buffer (150 mm Tris-HCl pH 7.6, 500 mm NaCl, 0.5% NaN 3 , 5% FCS) and fixed with 70% EtOH. Fixed cells were stained using 20 mg/ml propidium iodide (Sigma-Aldrich) and 200 mg/ml RNA-aseA (Kramel Biotech, Northumberland, UK), before being assayed on a Coulter Epics XL-MCL FACS machine.
Immunoblotting and immunoprecipitation
Cells were seeded into 100 mm dishes (5 Â 10 5 per plate) and then left for 24 h before being treated with 0, 5, 10 or 20 mm quercetin. Cells were treated for 36 h with new medium being added with fresh quercetin or EtOH after 24 h, before being harvested. Cells were harvested in 100 ml NP40 lysis buffer (0.1% NP40, 150 mm NaCl and 50 mm Tris-HCl pH 7.6 with a protease inhibitor cocktail; (Roche, Mannheim, GER) per plate and scraped into Eppendorf tubes on ice. Cells were lysed by being passed through an 18-gauge needle seven times and debris was pelleted by centrifugation at 14 K r.p.m. for 10 min at 41C. The supernatant was then taken and assayed for protein concentration by the BCA method (Sigma-Aldrich) and stored at À201C until use.
For Western blotting, 25-100 mg of cell lysate were first run on Tris-glycine-buffered SDS-PAGE gels utilizing MOPS pH buffer (Invitrogen), before being transferred to nitrocellulose membrane for probing. Membranes were blocked in 5% Marvel milk in PBS for 1 h at room temperature before being probed with the primary antibody for 1.5 h in 5% Marvel/PBS at room temperature. Membranes were washed three times for 10 min in PBS before the secondary antibody was added for 1 h at room temperature in 5% Marvel/PBS. Membranes were again thoroughly washed in PBS before being developed with ECL reagent (Amersham-Pharmacia, Bucks, UK). Primary antibodies used were: p105Rb ¼ IF8 (Santa Cruz, Santa Cruz,
. Secondary antibodies were antimouse IgG-HRP (Amersham-Pharmacia), anti-mouse IgM-HRP and anti-goat IgG-HRP (Santa Cruz). Bands were then analysed by densitometry using a UMAX Powerlook III Flatbed scanner and ImageQuant v5.2 software.
For immunoprecipitation, 250 mg of lysate was precleared using 4 mg of a nonspecific mouse monoclonal antibody (Santa Cruz) and 100 ml of Protein A-Sepharose beads (SigmaAldrich) for a total of 3 h in a total volume of 500 ml.
The supernatants were collected and cyclin E was immunoprecipitated using 1 mg of cyclin E antibody HE111 (Santa Cruz) for 1.5 h before addition of 30 ml of Protein A-Sepharose beads. The lysates were incubated, with agitation, for a further 1.5 h before the beads were pelleted and washed three times with ice-cold lysis buffer. A volume of 20 ml of Â 2 sample buffer (100 mm Tris-HCl pH 6.8, 4% SDS, 0.2% bromophenol blue, 20% glycerol, 200 mm DTT) was mixed with the beads. Beads were heated for 10 min at 701C. Samples were then assayed by immunoblotting as above.
Cyclin E-associated kinase assay
Cells were seeded into 100 mm dishes (5 Â 10 5 per plate) and then left for 24 h before being treated with 0, 5, 10 or 20 mm quercetin. Cells were treated for 36 h with new medium being added with fresh quercetin or EtOH after 24 h, before being harvested. Cells were lysed in E/K2 activity lysis buffer (50 mm HEPES pH 7.5, 150 mm NaCl, 1% NP40, 2.5 mm EGTA, 10 mm NaF, 10 mm b-glycerophosphate, 1 mm sodium orthovanadate, 1 mm DTT), by three freeze/thaw cycles. Lysate was spun at 14 K r.p.m. for 10 min to remove cell debris and the supernatant was assayed for protein concentration and stored at À701C. Cell lysate (500 mg) was used per assay, and cyclin E was precipitated with 4 mg of HE111 (Santa Cruz). Kinase activity was assayed by transfer of 32 P to Histone H1 as substrate at 301C for 30 min. Complexes were released from the beads by heating at 701C for 10 min before being run on a 10% acrylamide SDS-PAGE gel, dried and exposed to film (Kodak, Rochester, NY, USA).
Reporter gene analysis
HaCaT cells (2 Â 10 5 ) were plated into 60 mm dishes 24 h before transfection. Cells were transfected with 2 mg of pl34-11 or pGL3TK, and 2 mg of pCH110 as a transfection efficiency control using Lipofectamine (Invitrogen) for 5 h at 371C, 5% CO 2 in serum-free medium. Quercetin treatment started 24 h after transfection with 0-50 mm quercetin for 36 h with fresh medium every 24 h. Cells were harvested and assayed for luciferase activity with luciferase assay buffer (Promega, Madison, WI, USA) in a Dynex-MLX luminometer. Protein concentration was determined by BCA assay (Sigma-Aldrich) and b-galactosidase activity was measured by colour conversion of ONPG (Sigma-Aldrich) monitored at 420 nm.
Real time RT-PCR and standard RT-PCR
Total RNA was isolated from HFKE6/E7 cells using the RNeasy Minikit (Qiagen, Sussex, UK), and residual DNA was removed by DNA-aseI treatment according to the manufacturer's guidelines (Invitrogen). Real-time RT-PCR for p27 Kip1 , HPV16E7 and b-Actin mRNA was carried out using the TaqmanAE EZ RT-PCR Kit (Applied Biosystems, Foster City, CA, USA) with gene-specific primers and FAM/TAMRA probe designed by Primer Express v1.7 software. RNA (10 ng) was used per reaction, with each condition being carried out in triplicate. For p27 Kip1 , primers were p27FOR 5 0 -CCGGTG-GACCACGAAGAGT-3 0 and p27REV 5 0 -GCTCGCCTCTT-CCATGTCTC-3 0 with probe 5 0 -AACCCGGGACTTGGA-GAAGCACTGC-3 0 . For HPV16 E7, primers were E7FOR 5 0 -AAGTGTGACTCTACGCTTCGGTT-3 0 and E7REV 5 0 -CATGTATAGTTGTTTGCAGCTCTGTG-3 0 with probe 5 0 -TGCGTACAAAGCACACACGTAGACATTCGTA-3 0 . For b-Actin, the primers and probe were commercially available (Applied Biosystems). RT-PCR was performed using an ABI Prism 7700 Sequence detector. In each experiment, additional reactions with 8-10 10-fold serial dilutions of template DNA were performed with each set of primers and probes on the same 96-well plates to generate standard curves. All samples were amplified in duplicate. The relative amounts of p27 Kip1 , HPV16 E7 or b-Actin mRNA were determined by using the standard curve method. Levels of p27
Kip1 and HPV16 E7 mRNA were normalized to b-Actin mRNA expression levels. Standards, b-Actin control samples and either p27
Kip1 or HPV16 E7 test samples were analysed on the same 96-well plate for each individual experiment.
In addition, each RNA preparation used was tested for DNA contamination by using b-Actin primers and Taq polymerase instead of RT and Taq in standard RT-PCR reactions. RT and subsequent PCR of 200 ng of total RNA was carried out using gene-specific primers with OneStep RT-PCR Kit (Qiagen) according to the manufacturer's guidelines. b-Actin mRNA was amplified using the primers ACTINFOR 5 0 -GCGTCTGGACCTGGCTGGCCGGGACCT-3 0 and AC-TINREV 5 0 -GGAAGGCTGGAAGAGTGCCTCAGGG-CAG-3 0 . HPV16 E6 and E7 mRNA was detected in expressing cell lines using standard RT-PCR reactions. The OneStep RT-PCR Kit (Qiagen) was used according to the manufacturer's guidelines with gene-specific primers and 200 ng of total RNA. As with the Real-time RT-PCR, DNA contamination was assayed using Taq polymerase instead of RT and Taq. HPV16 E6 was amplified using the primers: E6 DETECT FOR: 5 0 GCGACCCAGAAAGTTACCAC 3 0 and E6 DETECT REV: 5 0 GCAACAAGACATACATCGACCGG 3 0 . HPV16 E7 was amplified using the primers: E7 DETECT FOR: 5 0 GCAAC-CAGAGACAACTGATCTC 3 0 and E7 DETECT REV: 5 0 TGGGGCACACAATTCCTAGTG 3 0 .
Cyclohexamide analysis of protein half-life
Protein half-life analysis of p27 Kip1 in HFKE6/E7 cells was carried out using cyclohexamide (CHX) (Sigma-Aldrich). Cells (5 Â 10 5 ) were seeded in 100 mm plates; then left for 24 h before being treated with 0, 5, 10 or 20 mm quercetin. Cells were treated for 36 h, with new medium being added with fresh quercetin or EtOH after 24 h, before being harvested. CHX in DMSO was added to a final concentration of 100 mg/ml to each plate and DMSO only was used as a negative control. Cells were harvested in NP40 lysis buffer (see above) at regular time intervals after CHX/DMSO addition. Lysates were then run on Tris-glycine-buffered SDS-PAGE gels utilizing MOPS pH buffer (Invitrogen), before being transferred to a nitrocellulose membrane for probing for p27 Kip1 . Bands were then analysed by densitometry using a UMAX Powerlook III Flatbed scanner and ImageQuant v5.2 software.
Results
Quercetin induces cell cycle arrest in HFK cells
Previous work in the bovine system showed that quercetin was capable of arresting primary fibroblasts in both G1 and G2/M phases of the cell cycle. The expression of the BPV-4 E7 oncoprotein with activated Ha-ras was capable of overcoming the G1, but not the G2/M, arrest (Beniston et al., 2001) . We reasoned that primary HFK cells might also undergo cell cycle arrest after quercetin exposure and that the HPV16 E6 and E7 oncoproteins might be able to abrogate this arrest.
Primary HFK cells were infected with a retrovirus expressing HPV16 E6 and/or E7. Cells were selected in G418 before being exposed to quercetin and assayed. To ensure that the HPV16 E6 and E7 oncogenes were expressed, RT-PCR was carried out to detect E6 and E7 mRNA. As a positive control, two HaCaT cell clones expressing tagged versions of the oncoproteins were used. DNA polymerase only (Taq) reactions without reverse transcriptase were carried out to detect contaminating DNA. Figure 1a shows that both E6 and E7 are expressed in the HFKE6, E7 and E6/E7 cell lines. The reduction in p53, with consequent reduction in p21
Waf1
, and of p105Rb, the main targets of E6 and E7, respectively (Mantovani and Banks, 2001; Munger et al., 2001) , confirmed the expression of the viral proteins (Figure 1b) . Additional confirmation of E7 expression was provided by the increase in p16 INK4a (Figure 1b) , which is correlated to E7 expression (Sano et al., 2002) .
Only the HFKE6/E7 cells will be discussed here. Primary HFK cells were exposed to 0-10 mm quercetin for 36 h, and HFKE6/E7 cells up to 20 mm. Cells were then fixed, stained with propidium iodide and assayed by FACS. Figure 2a shows that the primary HFK cells underwent a distinct increase in the G1 population after 36 h with 5 or 10 mm quercetin with a corresponding decrease in S and G2/M phases. Higher concentrations resulted in no further increase in the number of cells in G1 or decrease in the number of cells in G2/M (data not shown), leading to the conclusion that quercetin arrested the cells in G1. HFKE6/E7-transformed cells displayed an equivalent response to quercetin with an increase in G1 and decrease in S phase (Figure 2b ). It has been reported that quercetin can induce apoptosis (Iwashita et al., 2000; Rong et al., 2000; Yamashita and Kawanishi, 2000) ; however, we did not detect more than 2% apoptotic cells at the highest quercetin concentrations used, 20 mm (data not shown). Moreover, untreated HFKE6/E7 cells continued to expand over 72 h, whereas quercetin-treated HFKE6/E7 cells stopped proliferating, without a concomitant decrease in number (Figure 2c ). This showed that the cells were in fact arresting and not simply proliferating more slowly, or undergoing apoptosis. Hence, we can conclude that both primary and E6/E7 transformed human keratinocytes arrest in G1 upon quercetin treatment.
p27
Kip1 is elevated in HFK and HFKE6/E7 cells upon quercetin exposure
Earlier work had linked quercetin exposure to p53 elevation with an increase in p21
Waf1 (Plaumann et al., 1996; Beniston et al., 2001) , therefore both p53 and p21 Waf1 levels were assayed by immunoblotting. In addition, as quercetin caused G1 arrest in HFKE6/E7, two other cdk inhibitors associated with G1 cell cycle arrest, p16
INK4a and p27
Kip1
, were also examined. Figure 3a shows that in primary HFKs, p53 was only slightly elevated following quercetin exposure of 5-20 mm. However, the increase in p53 protein levels did not correlate to an increase of p21 Waf1 expression, and there was a noticeable decrease in the level of p21 Waf1 at 20 mm quercetin. At 50 mm quercetin, p53 protein levels increased further, while p21 Waf1 levels dropped below the level of detection (data not shown). The Waf1 , p53 and p105Rb protein levels and increase in p16
INK4a
protein levels in HFKE6/E7. Membranes were probed with D0-1 for p53, Ab3 for p21 Waf1 , DCS-50 for p16 INK4a and IF8 for p105Rb (top rows) and AB1 for b-Actin (bottom rows) related cdki p27 Kip1 , however, increased at 5-20 mm quercetin, suggesting that p27
Kip1 mediated the G1 arrest. HFKE6/E7 cells showed no change in p53, while p21
Waf1 showed a nonstatistically significant increase in response to quercetin and returned to basal levels at 20 mm quercetin (Figure 3b) . In HFKE6/E7 cells, as in primary cells, p27 Kip1 increased with quercetin exposure up to 20 mm, again suggesting its role in G1 arrest. Additionally, in primary HFK, p16
INK4a remained unchanged with quercetin treatment and actually decreased at 20 mm quercetin, whereas in HFKE6/E7 cells p16
INK4a decreased at 10 mm quercetin, indicating that this cdk4 inhibitor is unlikely to play an important role in quercetin-induced G1 arrest in these cells. These changes in cell cycle regulators following quercetin treatment were consistently observed over at least three experiments and are quantitated in Figure 3c and d.
Quercetin causes an increase in p27
Kip1 protein half-life
In agreement with the increase in the p27 Kip1 protein, quercetin caused an increase in the half-life of p27 , whereas cells treated with 100 mg/ml cyclohexamide (in DMSO) displayed a reduction in p27
Kip1 protein levels over 24 h (top two rows, Figure 4a ). This demonstrated that the cyclohexamide treatment was successful in inhibiting protein translation. Cells treated with 5-20 mm quercetin for 36 h and with cyclohexamide, displayed an increase in p27
Kip1 half-life. Protein bands were analysed by densitometry and data were normalized to the 0 h time point. After 36 h of 0 mm quercetin, p27
Kip1 half-life was calculated to be approximately 1.5 h, whereas after treatment with 5 mm quercetin, p27 Kip1 half-life was approximately 4 h. After treatment with 10 or 20 mm quercetin, p27
Kip1 half-life was as long as 24 h (Figure 4a) . A half-life of 1.5 h in normally cycling cells seemed high as p27
Kip1 half-life has been predicted to be in the region of around 30 to 40 min (Reinstein et al., 2000) . However, E6/E7 transformed cells do have a constitutively higher level of p27 Kip1 expression than primary cells (Figure 4b ), indicating some degree of base level activation. Indeed, it has been observed that p27
Kip1 levels are elevated in cervical lesions (Zehbe et al., 1999) .
To further investigate p27 Kip1 half-life in quercetintreated HFKE6/E7 cells, Skp2(p45) levels were assayed by Western blot analysis. Skp2(p45) is the F-box protein, which specifically recognizes p27
Kip1 (Carrano et al., 1999; Malek et al., 2001) and recruits it to the SCF core complex, thus promoting its ubiquitination and 
-----------------------9
Quercetin elevates p27 Kip1
Figure 3 p27
Kip1 protein is elevated in response to quercetin exposure in (a) primary HFK and (b) HFKE6/E7 cells. Cells were treated with 0-20 mm quercetin for 36 h before harvesting. Membranes were probed for p53 (top tow), p21
Waf1 (second row), p27 Kip1 (third row), p16
INK4a (fourth row) and b-Actin used as a loading control (bottom row). Variation in levels of cell cycle markers in (c) primary HFK and (d) HFKE6/E7 cells. Immunoblot bands were scanned, and analysed and normalized to b-Actin protein levels as control. Results are shown as fold increase over 0 mm quercetin. The number of experiments from which the histograms are derived is in brackets degradation, although there are suggestions that an Skp2(p45)-independent degradation of p27 Kip1 in G1 exists (Hara et al., 2001) . Analysis of Skp2(p45) levels in HFKE6/E7 showed that Skp2(p45) levels decreased as the concentration of quercetin increased (Figure 4c ). This effect is unlikely to be due to alterations in Skp2(p45) levels during the cell cycle, as in normally cycling cells, Skp2(p45) is low in early/mid-G1 and high in late G1, concomitant with the normal decrease in p27 Kip1 protein.
Reduction in cyclin E levels and increased association of p27 Kip1 with cyclin E correlate with decreased cyclin E-associated kinase activity
As quercetin treatment elevated p27
Kip1 protein levels and increased the protein's half-life, it was hypothesized that the cause of the G1 arrest in the cells was due to the activation of the cdki. To confirm this, cyclin Eassociated kinase (E/K2) assays were carried out. Cyclin E was immunoprecipitated and activity was assayed by transfer of 32 P to histone H1. Nonspecific IgG control immunoprecipitations showed no associated kinase activity (data not shown). Figure 5a shows that control cells had detectable E/K2 activity, whereas quercetin significantly decreased or completely abolished E/K2 activity even at 5 mm. Cyclin E was immunoprecipitated under identical conditions and immunoblotting revealed that its amount was approximately constant up to 10 mm quercetin (Figure 5a) . The observation was supported by separate Western blot analysis (Figure 5b) . The initial increase of cyclin E with 5 mm quercetin seen during immunoprecipitations (Figure 5a ) was not observed consistently (Figure 5b) .
To determine whether the loss of E/K2 activity was due to inhibition by p27 Kip1 , membranes were stripped and reprobed for p27 Kip1 . As can be seen in Figure 5a , the level of p27
Kip1 associated with cyclin E increased Figure 4 p27 Kip1 protein half-life is elevated in response to quercetin exposure in HFKE6/E7. (a) Cells were treated with 0 mm quercetin for 36 h before being treated with 100 mg/ml cyclohexamide (CHX) or DMSO control for up to 24 h. Samples were immunoblotted and membranes were probed for p27 Kip1 (upper two panels) to ensure CHX activity. Immunoblot assay of HFKE6/E7 cells were treated with 0-20 mm quercetin for 36 h, then with 100 mg/ml CHX for up to 24 h. Samples were immunoblotted and membranes were probed for p27 Kip1 (lower four panels). Densitometry was carried out on bands, normalized to protein levels at time point 0 h, and shown by graphical representation.
(b) Comparison of p27
Kip1 levels in both primary and HFKE6/E7 cells. Cells were treated with 0.5 or 20 mm quercetin for 36 h before harvesting. Membranes were probed for p27
Kip1 (top row) with Actin used as a loading control (bottom row). (c) Immunoblot assay of Skp2 (p45) protein levels (top row) with actin as a loading control (bottom row). Cells were treated with 0-20 mm quercetin for 36 h before harvesting Figure 5 Quercetin reduces cyclin E-associated kinase activity in HFKE6/E7 cells. Cells were treated with 0-10 mm quercetin for 36 h before harvesting. (a) Cyclin E-associated kinase activity was determined by radiolabelling of histone H1 by phosphorylation (top). Cyclin E immunoprecipitation was carried out in parallel as a loading control (middle). Membrane was then reprobed for p27 Kip1 (bottom row). (b) Membranes were probed for cyclin E (top tow) with Actin used as a loading control (bottom row) with increasing quercetin concentration. We interpret these results as an indication that quercetin raised the p27 Kip1 level associated with cyclin E, and this abolished cyclin E-associated kinase activity.
Quercetin treatment activates the p27
Kip1 promoter and results in increased mRNA levels A key control method for p27
Kip1 is post-translation control through its half-life (Lloyd et al., 1999; Nakayama et al., 2001 for reviews). However, other methods of control may also play a part. To examine possible transcriptional control, we used the human p27
Kip1 promoter directing the transcription of the firefly luciferase gene (pl34-11). The plasmid was transfected into HaCaT cells, which were then treated for 36 h with 0-20 mm quercetin before being harvested. Transfection efficiency was checked by cotransfection with the pCH110 b-galactosidase plasmid. Quercetin had no effect on expression of b-galactosidase from the SV40 promoter (data not shown). Figure 6 shows the average of four transcription assays each performed in duplicate, expressed as fold activation over control. The activity of the p27
Kip1 promoter increased significantly with increasing quercetin concentrations, from threefold at 5 mm to sixfold at 20 mm quercetin. Higher quercetin concentrations did not result in further increase of p27 Kip1 promoter activity (data not shown). The pGL3TK plasmid in which the tk promoter directs expression of luciferase (Vance et al., 1999) was used as a control to examine whether any possible effect observed was specific for the p27
Kip1 promoter or common to other promoters. There was no significant increase in the transcriptional activity of the tk promoter with increasing quercetin concentration ( Figure 6 ). These results indicate that quercetin-dependent trans-activation of the p27
Kip1 gene promoter acts via one or more elements specific to the promoter, and not on components of the basic transcription machinery.
Real-time RT-PCR was carried out to assay whether the increase in transcription activity of the p27 promoter resulted in elevated levels of p27
Kip1 mRNA. Figure Kip1 mRNA levels. Cells were treated with 0-20 mm quercetin for 36 h before total RNA was extracted. Real-time RT-PCR was carried out to determine p27 Kip1 mRNA levels and were normalized to b-Actin mRNA levels as a loading control. Results are shown as fold increase over 0 mm quercetin. (b) Quercetin does not affect HPV16 E7 mRNA levels. Cells were treated with 0-10 mm quercetin for 36 h before total RNA was extracted. Real-time RT-PCR was carried out to determine HPV16 E7 mRNA levels which were normalized to bActin mRNA levels as a loading control. Results are shown as fold change over 0 mm quercetin Quercetin treatment results in no alteration in HPV16 E7 mRNA levels Another key factor in the arrest of the HFKE6/E7 cells could be not only the elevation of the cdki p27
Kip1
, but also the reduction of the viral oncoprotein hypothesized to abrogate its function, that is, E7. As attempts to detect E7 in the HFKE6/E7 cells by immunoblotting were unsuccessful with available antibodies, a more indirect assessment method had to be undertaken. Realtime RT-PCR was carried out to determine whether quercetin treatment of these cells had any impact upon E7 mRNA levels. Figure 7b shows the average of four independent experiments each consisting of triplicate samples. Quercetin treatment resulted in no significant alteration in E7 mRNA levels. This would indicate that there is no variation in the level of HPV16 E7 due to quercetin exposure.
Discussion
Considerable evidence points to a possible cooperation or synergy between HPV infection and bracken fern in carcinogenesis of the upper GI tract in humans, as reported in cattle. People exposed to bracken fern, whether as spores or in the diet, are at greater risk of developing oesophageal and gastric carcinoma (Hirayama, 1979; Galpin et al., 1990; Villalobos-Salazar et al., 1995; Alonso-Amelot et al., 1996 Marliere et al., 2000) . Moreover, HPV-16 has been found in up to approximately 50% of oesophageal cancers and precancers in developing countries (Chang et al., 1990; Togawa et al., 1994; Cooper et al., 1995; Suzuk et al., 1996; de Villiers et al., 1999; Syrjanen, 2002) . There is a geographical overlap between consumption of bracken fern, infection of the alimentary canal mucosa by HPV and upper GI tract cancer, particularly in Asia and South America.
Our study aimed to determine whether quercetin treatment would cause cell cycle arrest in primary human keratinocytes, the natural host of HPV, as it does in a large variety of primary and transformed cell lines (Plaumann et al., 1996; Beniston et al., 2001; Casagrande and Darbon, 2001; Choi et al., 2001) . We hypothesized that expression of the HPV16 E6 and E7 oncogenes would abrogate the quercetin-induced cell cycle arrest thereby leading, as in the bovine model, to inheritable genetic alterations, the accumulation of which, together with the action of the viral oncoproteins, would increase the risk of full transformation of the cell.
Quercetin arrested both HFK and HFKE6/E7 cells in the G1 phase of the cell cycle. The data presented do not conclusively prove or disprove a G2/M arrest in either cell type in response to quercetin, and further investigation is yet to be conducted. Hence, here we have concentrated on the molecular mechanisms of the G1 arrest. In bovine cells, quercetin caused elevation of both p53 and p21
Waf1
; however, in the HFKE6/E7 cells, there was no significant p53 response over the full range of quercetin concentrations, although this may be due in part to E6-mediated degradation of p53. HFK cells did demonstrate a modest increase in p53 levels, but with no concomitant increase in p21
. These observations make it unlikely that p53 or p21
Waf1 play a necessary role in quercetin-induced G1 arrest in HFK cells.
Expression of E7 has been shown to overcome the effects of high levels of p16
INK4a , a member of the INK4 family of cdki (Martin et al., 1998) , and high expression of p16
INK4a has been correlated to E7 expression in cervical cancer samples (Sano et al., 2002) . Quercetin treatment lead to a reduction of p16
INK4a levels in both HFK and HFKE6/E7 cells, strongly indicating that p16
INK4a is unlikely to be the cause of the observed G1 arrest.
Quercetin caused a dose-dependent increase in p27
Kip1 levels in both primary and transformed cells. This was due to an increase in transcriptional activity of the p27 Kip1 gene and the concomitant increase in mRNA. In addition, the half-life of the protein increased too and this was accompanied by the reduction of the F box protein Skp2(p45), which promotes the turnover of p27
Kip1 (Carrano et al., 1999) . Increasing quercetin concentrations lead to increased association of p27 Kip1 with cyclin E and a corresponding decrease in cyclin Eassociated kinase activity. Altogether, these observations provide evidence that quercetin causes G1 arrest in HFK and HFKE6/E7 cells through p27 Kip1 . HPV16 E7 has been reported to bind directly to, and inhibit both p21
Waf1 and p27 Kip1 (Zerfass-Thome et al., 1996; Funk et al., 1997; Jones et al., 1997a) . Additionally, high levels of p21
Waf1 and p27 Kip1 have been found in cervical samples containing HPV16 (Zehbe et al., 1999) . While our study does not examine the effect of E7 on p21 Waf1 , it is interesting that in HFKE6/E7 cells p27 Kip1 is the most likely cause of G1 arrest upon quercetin exposure. In agreement with others, we noted an increased expression of p27 Kip1 in HFKE6/E7 cells (Figure 4b ). This high level of p27 Kip1 may be tolerated by the E7-expressing cells, causing a significant level of cdk2 activity to be retained. Upon quercetin treatment, however, the amount of p27 Kip1 raises still further and possible alterations in post-translational modification of p27
Kip1 could promote an inhibitory role on cell cycle progression, such as alleviation of PKB phosphorylation (Liang et al., 2002) .
The failure of HFK16 E6/E7 cells to overcome quercetin-induced G1 arrest does not disprove the role of either HPV or bracken fern in the aetiology of human oesophageal carcinoma. There are several reasons to account for the different outcome of quercetin treatment of PV-transformed bovine and human cells: bovine fibroblasts may intrinsically respond to quercetin differently from human keratinocytes. This would be supported by the observation that quercetin induces both p53 and p21
Waf1 in bovine fibroblasts (Beniston et al., 2001) , but p27
Kip1 in HFK (Figure 3) . Moreover, the major difference between our bovine and human in vitro systems is the absence of activated Ha-ras in the HFKE6/E7 cells. Activated Ha-ras, seen in BPV-4 associated carcinoma, was required for immortalization of BPV-4-transformed cells, due to the lack of the E6 gene in BPV-4 (Jackson et al., 1991) . Members of the ras gene family are often overexpressed or amplified (Sorsdahl et al., 1994; Galiana et al., 1995) in human oesophageal cancers, implicating the ras proteins in oesophageal carcinogenesis, although activating point mutations are rare (Casson et al., 1997; Arber et al., 2000) . It would be informative to ascertain what effects quercetin would have in HFKE6/E7 overexpressing ras. Furthermore, bracken fern contains numerous mutagens and carcinogens in addition to quercetin, including the sesquiterpene ptaquiloside. Ptaquiloside has been shown to be one of the active chemicals in bracken fern in Salmonella and in rats (Hirono et al., 1987; Matoba et al., 1987; Potter and Baird, 2000) . It will be important to test ptaquiloside in HFK16 E6/E7 cells.
